Patents by Inventor Clifton L. DALGARD

Clifton L. DALGARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azophenols as ERG oncogene inhibitors
    Patent number: 11648239
    Abstract: Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II) wherein X, X1, X2, X3, X4 and X5, R1 through R4 and R9 are as described.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: May 16, 2023
    Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Albert L. Dobi, Clifton L. Dalgard, Shiv K. Srivastava
  • AZOPHENOLS AS ERG ONCOGENE INHIBITORS
    Publication number: 20210299106
    Abstract: Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II) wherein X, X1, X2, X3, X4 and X5, R1 through R4 and R9 are as described.
    Type: Application
    Filed: January 26, 2021
    Publication date: September 30, 2021
    Inventors: Albert L. Dobi, Clifton L. Dalgard, Shiv K. Srivastava
  • Biomarkers for diagnosing post traumatic stress disorder
    Patent number: 11085934
    Abstract: The invention relates to methods of determining if a subject is at risk of developing post-traumatic stress disorder (PTSD).
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: August 10, 2021
    Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Harvey B. Pollard, Clifton L. Dalgard
  • Azophenols as ERG Oncogene Inhibitors
    Publication number: 20190336485
    Abstract: Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II) wherein X, X1, X2, X3, X4 and X5, R1 through R4 and R9 are as described.
    Type: Application
    Filed: February 15, 2019
    Publication date: November 7, 2019
    Applicant: The Henry M. Jackson Foundation for the Advancemen t of Military Medicine, Inc.
    Inventors: Albert L. DOBI, Clifton L. DALGARD, Shiv K. SRIVASTAVA
  • BIOMARKERS FOR DIAGNOSING POST TRAUMATIC STRESS DISORDER
    Publication number: 20190113526
    Abstract: The invention relates to methods of determining if a subject is at risk of developing post-traumatic stress disorder (PTSD).
    Type: Application
    Filed: October 6, 2016
    Publication date: April 18, 2019
    Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Harvey B. POLLARD, Clifton L. DALGARD
  • Azophenols as ERG oncogene inhibitors
    Patent number: 10238639
    Abstract: Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II) wherein X, X1, X2, X3, X4 and X5, R1 through R4 and R9 are as described.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: March 26, 2019
    Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Albert L. Dobi, Clifton L. Dalgard, Shiv K. Srivastava
  • Azophenols as ERG Oncogene Inhibitors
    Publication number: 20180169074
    Abstract: Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II) wherein X, X1, X2, X3, X4 and X5, R1 through R4 and R9 are as described.
    Type: Application
    Filed: September 9, 2016
    Publication date: June 21, 2018
    Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Albert L. DOBI, Clifton L. DALGARD, Shiv K. SRIVASTAVA